Viatris Inc: Drug Recall

Recall #D-0120-2025 · 11/18/2024

Class II: Risk

Recall Details

Recall Number
D-0120-2025
Classification
Class II
Product Type
Drug
Recalling Firm
Viatris Inc
Status
Ongoing
Date Initiated
11/18/2024
Location
Canonsburg, PA, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9,828 bottles

Reason for Recall

Superpotent Drug and Subpotent Drug: potency failures obtained

Product Description

Levothyroxine Sodium Tablets USP, 150 mcg, packaged in a) 90-count bottles (NDC 0378-1815-77) and b) 1000-count bottles (NDC 0378-1815-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

Distribution Pattern

Nationwide within the United States and Puerto Rico

Other Recalls by Viatris Inc

View all recalls by Viatris Inc →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.